HomeFilePharmacology

Pharmacology

View Category

Acute coronary syndromes

How To De-Escalate Prasugrel After Acute Coronary Syndrome?

Patients who undergo coronary angioplasty after acute coronary syndrome could de-escalate dual antiplatelet therapy with prasugrel to...
solaci -
Learn More
Acute coronary syndromes

Diabetes Could Decide between Ticagrelor and Prasugrel

Diabetes has an impact on the relative effect of ticagrelor and prasugrel in patients undergoing acute coronary...
solaci -
Learn More
Antiplatelet

Post TAVR ASA Monotherapy Consolidates

This meta-analysis to be published in J Am Cardiol supports the use of aspirin monotherapy (ASA) after...
solaci -
Learn More
Information for Patients

What Is the Healthiest Diet?

This review published in JACC focuses on the foods we shood consume rather than the foods we...
solaci -
Learn More
Antiplatelet

Ticagrelor to Improve Venous Graft Patency

Saphenous vein graft patency is one of CABG’s “Achilles heals”, especially after the ARTS trial came out...
solaci -
Learn More
Antiplatelet

Evidence or Theory? Antiaggregation Scheme after Peripheral Vascular Intervention

Antiaggregation indication after peripheral intervention (PVI) can vary up to 50% depending on center, operator, and procedure.  This...
solaci -
Learn More
Acute coronary syndromes

ESC 2020 | Ticagrelor Might Increase Bleeding and Mortality in the Elderly

Ticagrelor compared against clopidogrel produces more bleeding and also more deaths in patients over 80 recently undergoing...
solaci -
Learn More
Other

ESC 2020 | Antihypertensive Therapy Reduces Events Regardless of BP Levels or Risk

Antihypertensive therapy reduces the risk of cardiovascular events even in patients with no history of heart disease...
solaci -
Learn More